FDA Approves Orphan Drug Fidaxomicin for Pediatric CDI The FDA has granted orphan drug designation for all formulations of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant. To investigate whether ...

A 70-year-old woman with a history of Clostridium difficile infection returned to the clinic with abdominal pain and diarrhea. Three stool samples were negative for C. difficile and WBCs. Would you ...

Transplanting faecal matter from one person to another — the thought might turn your stomach, but it could be lifesaving. Some doctors are using the procedure to repopulate the gut with healthy ...

Clostridioides difficile infection (CDI) arises predominantly in healthcare settings following antibiotic-mediated disruption of the gut microbiota. Patients may present a spectrum from asymptomatic ...

PARIS (Reuters) - Sanofi said on Monday it had started late-stage trials involving 15,000 people to test a vaccine against Clostridium difficile infections (CDI), the main cause of diarrhea in ...

Clostridioides difficile is a notoriously nasty intestinal bug, with few effective treatments and no approved vaccines. But the same technology that enabled the first COVID-19 vaccines has shown early ...